Eltrombopag for secondary failure of platelet recovery post-allogeneic hematopoietic stem cell transplant in children. (åbner nyt vindue)

Ali S, Gassas A, Kirby-Allen M, Krueger J, Ali M, Schechter T

Kilde‎: Pediatr Transplant 2017;21(6):e13017.

Indekseret‎: PubMed 28653480

DOI‎: 10.1111/petr.13017

https://www.ncbi.nlm.nih.gov/pubmed/28653480 (åbner nyt vindue)

The role of interleukin-11 to prevent chemotherapy-induced thrombocytopenia in patients with solid tumors, lymphoma, acute myeloid leukemia and bone marrow failure syndromes. (åbner nyt vindue)

Bhatia M, Davenport V, Cairo MS.

Kilde‎: Leuk Lymphoma 2007;48(1):9-15.

Indekseret‎: PubMed 17325843

DOI‎: 10.1080/10428190600909115

https://www.ncbi.nlm.nih.gov/pubmed/17325843 (åbner nyt vindue)

Recombinant human interleukin 11 and bacterial infection in patients with haematological malignant disease undergoing chemotherapy: a double-blind placebo-controlled randomised trial. (åbner nyt vindue)

Ellis M, Zwaan F, Hedström U, Poynton C, Kristensen J, Jumaa P, Wassell J, al-Ramadi B.

Kilde‎: Lancet 2003;361(9354):275-80.

Indekseret‎: PubMed 12559860

https://www.ncbi.nlm.nih.gov/pubmed/12559860 (åbner nyt vindue)

Romiplostim for immune thrombocytopenia in neuroblastoma patients receiving chemotherapy. (åbner nyt vindue)

Fassel H, Bussel JB, Roberts SS, Modak S

Kilde‎: J Pediatr Hematol Oncol 2019;41(4):e257-9.

Indekseret‎: PubMed 29683946

DOI‎: 10.1097/MPH.0000000000001187

https://www.ncbi.nlm.nih.gov/pubmed/29683946 (åbner nyt vindue)

Romiplostim for therapy-related thrombocytopenia in pediatric malignancies. (åbner nyt vindue)

Jacobson AE, Shah N, Setty BA

Kilde‎: Pediatr Blood Cancer 2017;64(8):e26473.

Indekseret‎: PubMed 28150377

DOI‎: 10.1002/pbc.26473

http://www.ncbi.nlm.nih.gov/pubmed/28150377 (åbner nyt vindue)

Eltrombopag for delayed platelet recovery and secondary thrombocytopenia following allogeneic stem cell transplantation in children. (åbner nyt vindue)

Li S, Wu R, Wang B, Fu L, Zhu G, Zhou X, Ma J, Zhang L, Qin M

Kilde‎: J Pediatr Hematol Oncol 2019;41(1):38-41.

Indekseret‎: PubMed 30080752

DOI‎: 10.1097/MPH.0000000000001263

https://www.ncbi.nlm.nih.gov/pubmed/30080752 (åbner nyt vindue)

Romiplostim for secondary thrombocytopenia following allogeneic stem cell transplantation in children. (åbner nyt vindue)

Maximova N, Zanon D, Rovere F, Maestro A, Schillani G, Paparazzo R

Kilde‎: Int J Hematol 2015;102(5):626-32.

Indekseret‎: PubMed 26084627

DOI‎: 10.1007/s12185-015-1821-1

https://www.ncbi.nlm.nih.gov/pubmed/26084627 (åbner nyt vindue)

Recombinant human erythropoietin reduces the need for erythrocyte and platelet transfusions in pediatric patients with sarcoma: a randomized, double-blind, placebo-controlled trial. (åbner nyt vindue)

Porter JC, Leahey A, Polise K, Bunin G, Manno CS

Kilde‎: J Pediatr 1996;129(5):656-60.

Indekseret‎: PubMed 8917229

DOI‎: 10.1016/s0022-3476(96)70145-2

https://www.ncbi.nlm.nih.gov/pubmed/8917229 (åbner nyt vindue)

Chemotherapy induced thrombocytopenia in pediatric oncology. (åbner nyt vindue)

Tamamyan G, Danielyan S, Lambert MP

Kilde‎: Crit Rev Oncol Hematol 2016;99:299-307.

Indekseret‎: PubMed 26811139

DOI‎: 10.1016/j.critrevonc.2016.01.005

https://www.ncbi.nlm.nih.gov/pubmed/26811139 (åbner nyt vindue)

Oncological management of pediatric cancer patients belonging to Jehovahs Witnesses: a two-institutional experience report. (åbner nyt vindue)

Tenenbaum T, Hasan C, Kramm CM, Janssen G, Laws HJ, Wessalowski R, Bode U, Göbel U

Kilde‎: Onkologie 2004;27(2):131-7.

Indekseret‎: PubMed 15138344

DOI‎: 10.1159/000076901

https://www.ncbi.nlm.nih.gov/pubmed/15138344 (åbner nyt vindue)

Low-dose interleukin-11 in patients with bone marrow failure: update of the M. D. Anderson Cancer Center experience. (åbner nyt vindue)

Tsimberidou AM, Giles FJ, Khouri I, Bueso-Ramos C, Pilat S, Thomas DA, Cortes J, Kurzrock R.

Kilde‎: Ann Oncol 2005;16(1):139-45.

Indekseret‎: PubMed 15598951

DOI‎: 10.1093/annonc/mdi007

https://www.ncbi.nlm.nih.gov/pubmed/15598951 (åbner nyt vindue)

Safety and cost effectiveness of a 10 x 10(9)/L trigger for prophylactic platelet transfusions compared with the traditional 20 x 10(9)/L trigger: a prospective comparative trial in 105 patients with acute myeloid leukemia. (åbner nyt vindue)

Wandt H, Frank M, Ehninger G, Schneider C, Brack N, Daoud A, Fackler-Schwalbe I, Fischer J, Gäckle R, Geer T, Harms P, Löffler B, Ohl S, Otremba B, Raab M, Schönrock-Nabulsi P, Strobel G, Winter R, Link H

Kilde‎: Blood 1998;91(10):3601-6.

Indekseret‎: PubMed 9572994

https://www.ncbi.nlm.nih.gov/pubmed/9572994 (åbner nyt vindue)